Liquidators of biotech startup in talks over stake in drug firm

Liquidators of biotech startup in talks over stake in drug firm
Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)
Riley Kennedy
Liquidators of a collapsed animal-breeding startup are in talks about its stake in another drug development company.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise of $800,000 in 2016.However, it collapsed in June last year after failing to find enough commercial contracts for its pr...

More Primary Sector

Meet NZ’s top ‘fish cop’ Steve Ham
Primary Sector

Meet NZ’s top ‘fish cop’ Steve Ham

Protecting NZ’s fisheries resources is his life’s work. 

Jem Traylen 06 Feb 2025
Zhiqiang Li takes helm as acting CEO of Westland Milk Products
Primary Sector

Zhiqiang Li takes helm as acting CEO of Westland Milk Products

Zhiqiang Li has taken the helm as acting chief executive of Westland Milk Products, effective today.The move follows the resignation of former CEO Richard Wyeth.Li will continue as executive director of Yili Group in Australia and New Zealand.Li said Wyeth joined the company four...

Rebecca Howard 31 Jan 2025
Coal and gold added to critical minerals list
Finance

Coal and gold added to critical minerals list

Banks and insurance companies threatened with regulatory retaliation if they block mining.

Ian Llewellyn 31 Jan 2025